| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |